Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04002089Phase 1Completed
Phase 1, open-label trial of liposomal bupivacaine in postoperative pain (4 cohorts), sponsored by Pacira BioSciences. Primary endpoints: Area under the plasma concentration up to 168 hours, Maximum plasma concentration up to 168 hours and 5 more. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04002089.